System Pharm participated in the Movember 2025

#SYSTEMPHARM #UKRAINE

System Pharm participated in the Movember 2025 Conference: Supporting Urology and Men’s Health in Ukraine

System Pharm took part in the scientific and practical conference Movember 2025, held on November 14–15 in Kyiv and online. The event became one of the key medical conferences of the year in Ukraine and was dedicated to innovations in oncourology, diagnostics, and treatment of prostate cancer and urinary system disorders.

Movember 2025: the key event of the year in men’s health

The annual Movember conference brings together leading specialists in urology and oncourology. In 2025, participants had the opportunity to attend the Virtual ESU – EAU Oncology course, “Update on Prostate Cancer: What’s New in 2025?”, which highlighted the latest trends in the treatment and prevention of prostate cancer.

The event was organized by the Association of Oncourologists of Ukraine and became an important platform for the professional development of Ukrainian physicians.

System Pharm’s participation in the conference

System Pharm served as an event partner and supported the international educational course. Our participation reflects the company’s strategic focus on developing the urological field and implementing modern therapeutic solutions in Ukraine.

Why this matters for Ukraine’s medical community

The Movember 2025 conference was a significant event for urologists, oncologists, and family physicians. Participants received updated information on:

• modern methods of prostate cancer treatment
• international oncourology standards
• new approaches to men’s health preservation
• practical cases and clinical recommendations

Such events help improve the quality of medical care in Ukraine and build a strong professional ecosystem.

The importance of System Pharm’s participation

For System Pharm, participating in Movember 2025 is part of our long-term strategy to support evidence-based medicine, professional education, and the development of pharmacotherapy in the field of urology.

We will continue to support scientific initiatives and create opportunities for Ukrainian doctors to gain the most up-to-date knowledge.